logo

HIMS

Hims & Hers Health·NYSE
--
--(--)
--
--(--)
7.24 / 10
Outperform

Assessment shows good fundamentals at 7.2/10. Constructive elements: Net cash flow from operating activities per share (YoY growth rate %) and Revenue-MV, whereas limitations surface in Cash-MV and Net income-Revenue. Investment case: promising.

Fundamental(7.24)SentimentTechnical

Analysis Checks(7/10)

Revenue-MV
Value-0.72
Score3/3
Weight23.93%
1M Return9.68%
Net cash flow from operating activities per share (YoY growth rate %)
Value38.76
Score3/3
Weight11.74%
1M Return5.16%
Net income-Revenue
Value-1.58
Score1/3
Weight4.80%
1M Return2.53%
Basic earnings per share (YoY growth rate %)
Value2.13
Score3/3
Weight10.40%
1M Return4.75%
Total profit (YoY growth rate %)
Value113.62
Score3/3
Weight13.53%
1M Return6.14%
Net cash flow from operating activities (YoY growth rate %)
Value44.93
Score3/3
Weight12.01%
1M Return5.21%
Diluted earnings per share (YoY growth rate %)
Value0.00
Score3/3
Weight11.24%
1M Return5.10%
Asset-MV
Value-0.50
Score1/3
Weight3.64%
1M Return1.95%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value7.75
Score3/3
Weight8.92%
1M Return4.09%
Cash-MV
Value-0.61
Score1/3
Weight-0.20%
1M Return-0.11%
Is HIMS fundamentally strong?
  • HIMS scores 7.24/10 on fundamentals and holds a Discounted valuation at present. Backed by its 20.38% ROE, 6.05% net margin, 26.87 P/E ratio, 8.96 P/B ratio, and 22.92% earnings growth, these metrics solidify its Outperform investment rating.